From: Health-related quality of life in patients with primary immunodeficiency disease
Study | IVIG, SCIG or both | Adult or pediatric patients | Number of patients | Tools used | Summary |
---|---|---|---|---|---|
Quality of life in PIDD Patients | |||||
Al-Herz et al. [69] | IVIG | Pediatric | 98 | LPPS | Patients with PIDD had poor performance status. Variables shown to have a positive effect on LPPS score included antimicrobial prophylaxis and IVIG therapy |
Tcheurekdijian et al. [70] | IVIG | Adults | 58 | SF-36 | Compared with age and sex matched diabetic and congestive heart failure patients, CVID patients on IVIG had significantly lower scores in general health and mental health. Compared with diabetic patients, CVID patients scored lower across all subscales with statistical significance in 6 of the 8 domains |
Zebracki et al. [20] | IVIG | Pediatric | 72 | CHQ-PF50 | Compared with age matched normal controls, PIDD patients on IVIG reported greater limitations in physical functioning, school related and social activities, general health, parental time emotional distress and limitations in family activities |
Soresina et al. [18] | IVIG | Pediatric | 25 | PedsQL 4.0 | X-linked agammaglobulinemia children had a significantly lower total score of HRQOL, psychosocial health, emotional functioning, social functioning and school functioning compared to healthy controls |
Aghamohammadi et al. [21] | IVIG | Adults | 36 | SF-36 | PIDD patients scored lower in physical and mental components compared to healthy controls. A reverse association was also noted between SF-36 scores and number of infectious episodes and long delays in diagnosis |
Tabolli et al. [19] | Both | Adult and pediatric | 96 | SF-36; GHQ-12 | CVID patients scored lower on the GHQ-12 than patients with other chronic diseases. Over 6Â years of longitudinal assessment, a decline in the score on SF-36 scales was observed between the first and the last assessment for the Physical Functioning, Body Pain, General Health, Social Functioning, and Role-Emotional scales. The relative risk (RR) of death associated with PF and SF scales were noted to be 0.98 and 0.97 respectively, independent of patient age |
IVIG in Home versus Hospital/Doctor’s Office | |||||
Daly et al. [9] | IVIG- home based, self-infused | Adult and Pediatric | 66 total  37 home  29 clinic | LQI (Daly); HOS; MHLC | Home based IVIG group revealed improved independence, convenience, comfort, decreased disruption of activities, travel time and costs |
Espanol et al. [61] | IVIG, SCIG | Adult and Pediatric | 300 total  160 IVIG  134 SCIG  6 other IG  150 home | SF-12; EQ-5D | Patients and caregivers prefer home treatment and less frequent self-administration of shorter duration with fewer needle sticks. Respondents receiving IVIG and those receiving SCIG had similar results though respondents receiving SCIG had a relatively higher preference for self-administration |
IVIG versus SCIG | |||||
Berger et al. [71] | SCIG previously on IVIG | Adult and pediatric | 51 | SF-36; CHQ-PF50 | Adult patients had improvement in general health perception, vitality and mental health at 6Â months and general health perception at 12Â months. Children had improvements in general health at 6 and 12Â months |
Fasth et al. [72] | SCIG previously on IVIG | Pediatric | 12 | CHQ (Swedish version) | Patients and the parents of patients receiving SCIG had improvements in child-rated global health and social limitations subscale scores and parent-rated mental health, child’s general health and emotional impact and had significantly fewer days off school and workdays |
Fasth et al. [73] | SCIG previously on IVIG | Pediatric | 12 | CHQ (Swedish version) | Parents noted significant improvements at 6 months in the child’s mental health, a change in health from 1 year ago and family activities. From the children’s perspective at 6 months there were significant improvements in global health and in role limitations and emotional social limitations |
Hoffman et al. [39] | SCIG Previously on IVIG | Adult and pediatric | 30 | SF 36; CHQ-PF50 | There was a significant improvement in general health perceptions, parental impact-emotional, parental impact-time, and family activities. At follow-up, 92Â % of adults stated a preference for SCIG over IVIG therapy and 83Â % preferred home therapy over therapy in clinic setting |
Nicolay et al. [10] | SCIG vs IVIG | Adult and pediatric | 58 (47 on IVIG prior to study) | LQI (Daly); CHQ-PF50; SF-36 | In adults there was significantly increased satisfaction in scales of treatment interference and therapy setting in patients switching from IVIG to SCIG |
Vultaggio et al. [52] | SCIG previously on IVIG and alternate SCIG | Adult and pediatric | 40 (44 on IVIG prior to study, 6 on alternate SCIG prior to study) | LQI; CHQ-PF50; SF-36 | In patients changing from IVIG to SCIG, no significant difference was seen in the SF-36 for patients over 14Â years old or in the CHQ-PF50 answered by the caregivers of patients less than 14Â years old but in both groups total mean LQI significantly improved at 6Â months and the improvement was sustained over the 24Â month follow-up period |